http://www.igenericdrugs.com Review Rating: 100 out of 100 based on 470 reviews. 470 stars
Generic drugs
List of interchangeable brand and generic drugs
compare generic drug prices
 

Dexavet

Search a suitable generic or branded drugs, if you could not find the prescribed medicine. This site does not supply any medicines. It contains prices for information purposes only. You should consult a doctor about the dosage before using this medicine!

DRUG NAME:     

 

Dexavet uses and description

Sort by popularity
Dexavet - Dexavet is a steroid that prevents the release of substances in the body that cause inflammation.

Dexavet is used to treat many different conditions such as allergic disorders, skin conditions, ulcerative colitis, arthritis, lupus, psoriasis, or breathing disorders.

Dexavet may also be used for purposes not listed in this medication guide.

Pharmacology: Synthetic long-acting glucocorticoid that depresses formation, release, and activity of endogenous mediators of inflammation, including prostaglandins, kinins, histamine, liposomal enzymes, and complement expression. It also modifies the body\'s immune response.

Indication: Testing of adrenal cortical hyperfunction; management of allergic and inflammatory ophthalmic processes, allergic states, cerebral edema associated with primary or metastatic brain tumor, collagen diseases, craniotomy or head injury, dermatologic diseases, edematous states (caused by nephrotic syndrome), endocrine disorders, GI diseases, hematologic disorders, multiple sclerosis, neoplastic diseases, renal diseases, respiratory diseases, rheumatic disorders, trichinosis with neurologic or myocardial involvement, and tuberculous meningitis.

Intra-articular or soft-tissue administration

Short-term adjunctive treatment for conditions such as acute gouty arthritis, posttraumatic osteoarthritis, rheumatoid arthritis, and synovitis of osteoarthritis.

Intralesional administration

Treatment for conditions such as alopecia areata, discoid lupus erythematosus, keloids, and psoriatic plaques.

Intravitreal implant

Treatment of macular edema following branch retinal vein occlusion or central retinal vein occlusion; treatment of noninfectious uveitis affecting the posterior segment of the eye.

Ophthalmic

Treatment of steroid-responsive inflammatory conditions of palpebral and bulbar conjunctiva, lid, cornea, and anterior segment of globe; sympathetic ophthalmia; temporal arteritis; uveitis.

Otic (using ophthalmic solution)

Steroid-responsive inflammatory conditions of the external auditory meatus, such as allergic otitis externa.

Unlabeled Uses

Treatment of acute and chronic asthmatic bronchitis; acute calcium pyrophosphate deposition disease; adjunctive treatment for bacterial meningitis; adjunct treatment for brain neoplasm; adjunct treatment for fever caused by malignant neoplasm; airway-obstructing hemangioma in infants; cerebral ischemia; cerebri pseudomotor; connective tissue disease; croup; desquamative gingivitis; diagnosis of endogenous depression; hemolysis; localized cutaneous sarcoid; mixed breast and prostatic carcinoma; multiple myeloma; myasthenia gravis; nasal polyps; noncardiogenic pulmonary edema; nonrheumatic carditis; oral lesions associated with corticosteroid responsive disorder; organ transplant rejection; pemphigoid; pericarditis; polyarteritis nodosa; prevention of nausea and vomiting associated with chemotherapy, especially cisplatin-containing regimens; prophylaxis for acute mountain sickness; recurrent aphthous stomatitis; Reiter disease; relapsing polychondritis; respiratory distress syndrome; rheumatic fever; sarcoidosis; severe eczema; vasculitis.

Dexavet is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet inhibits the activity of phospholipase A2, which leads to suppression of the synthesis of prostaglandins and leukotrienes.

With direct application to the vessels this drug has a vasoconstrictor effect.

Dexavet has a pronounced dose-dependent effect on the metabolism of carbohydrates, proteins and fats.

In high doses Dexavet may increase the excitability of brain tissue and contributes to lowering the threshold of convulsive readiness.

With systemic use of therapeutic activity of Dexavet is due to anti-inflammatory, antiallergic, immunosuppressive and antiproliferative action.

For external and local use of therapeutic activity of Dexavet is due to anti-inflammatory, antiallergic and antiexudative (due to vasoconstrictor effect) effect.

Dexavet and its derivatives, Dexavet sodium phosphate and Dexavet acetate, are synthetic glucocorticoids. Used for its antiinflammatory or immunosuppressive properties and ability to penetrate the CNS, Dexavet is used alone to manage cerebral edema and with tobramycin to treat corticosteroid-responsive inflammatory ocular conditions.

Dexavet is in a class of drugs called steroids. Dexavet prevents the release of substances in the body that cause inflammation.

Dexavet (Jen Sheng) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (Jen Sheng) may also be used to prevent organ transplant rejection after a transplant. Dexavet (Jen Sheng) may be used for other purposes as decided by your doctor. Dexavet (Jen Sheng) belongs to a group of medicines called steroids.

Dexavet (Swiss) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (Swiss) may also be used to prevent organ transplant rejection after a transplant. Dexavet (Swiss) may be used for other purposes as decided by your doctor. Dexavet (Swiss) belongs to a group of medicines called steroids.

Oral Anti-inflammatory

Adult: 0.75-9 mg daily in 2-4 divided doses; may also be given via IM/IV admin.

Child: 1 mth-18 yr: 10-100 mcg/kg daily in 1-2 divided doses via oral admin, adjusted according to response; up to 300 micrograms/kg daily may be used in emergency situations. Oral As a screening test for Cushing\'s syndrome

Adult: 0.5 mg every 6 hr for 48 hr after determining baseline 24-hr urinary 17-hydroxycorticosteroid (17-OHCS) concentrations. During the second 24 hr of Dexavet admin, urine is collected and analysed for 17-OHCS. Alternatively, after a baseline plasma cortisol determination, 1 mg may be given at 11 pm and plasma cortisol determined at 8 am the next morning. Plasma cortisol and urinary output of 17-OHCS are depressed after Dexavet admin in normal individuals but remain at basal levels in patients with Cushing\'s syndrome. Oral Acute exacerbations in multiple sclerosis

Adult: 30 mg daily for 1 wk followed by 4-12 mg daily for 1 mth.

Child: 1 mth-12 yr: 100-400 mcg/kg daily in 1-2 divided doses; 12-18 yr: Initially 0.5-24 mg daily. Max. 24 mg daily. Parenteral Cerebral oedema caused by malignancy

Adult: As phosphate: 10 mg IV followed by 4 mg IM every 6 hr until response is achieved, usually after 12-24 hr. May reduce dosage after 2-4 days then gradually discontinued over 5-7 days. In severe cases, an initial dose of 50 mg IV may be given on day 1, with 8 mg every 2 hr, reduced gradually over 7-13 days. Maintenance dose: 2 mg 2-3 times daily.

Child: As phosphate: <35 kg: Initially 20 mg, then 4 mg every 3 hr for 3 days, then 4 mg every 6 hr for 1 day, then 2 mg every 6 hr for 4 days, then decrease by 1 mg daily. >35 kg: Initially 25 mg, then 4 mg every 2 hr for 3 days, then 4 mg every 4 hr for 1 day, then 4 mg every 6 hr for 4 days, then decrease by 2 mg daily. Doses are given via IV inj. Intra-articular Inflammatory joint diseases

Adult: 0.8-4 mg depending on the size of the affected joint. For soft-tissue inj, 2-6 mg may be used. May repeat inj every 3-5 days to every 2-3 wk. Intravenous Unresponsive shock

Adult: As phosphate: Initially, 40 mg or 1-6 mg/kg as a single IV inj, may repeat every 2-6 hr. Continue high-dose treatment only until patient\'s condition has stabilised and not to be continued beyond 48-72 hr. Intravenous Bacterial meningitis

Adult: 0.15 mg/kg 4 times daily, to be given 10-20 min before or with the 1st dose of anti-infective treatment. Treatment should be given for the first 2-4 days of the anti-infective treatment.

Child: As phosphate: 2 mth-18 yr: 150 mcg/kg every 6 hr for 4 days, starting before or with 1st dose of antibacterial treatment. Intravenous Prophylaxis of nausea and vomiting associated with cytotoxic therapy

Adult: Prevention: 10-20 mg 15-30 minutes before admin of chemotherapy on each treatment day. For continuous infusion regimen: 10 mg every 12 hr on each treatment day. For midly emetogenic regimen: 4 mg every 4-6 hr. Ophthalmic Ocular inflammation

Adult: As 0.1% suspension: Apply 1-2 drops into the affected eye/s 4-6 times daily in mild disease, up to hrly admin in more severe disease. As 0.05% ointment: Apply 0.5-1 inch ribbon of ointment into the conjunctival sac(s) up to 4 times daily. Reduce to once daily dosing once conditon has improved.

Dexavet (S.Y.) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (S.Y.) may also be used to prevent organ transplant rejection after a transplant. Dexavet (S.Y.) may be used for other purposes as decided by your doctor. Dexavet (S.Y.) belongs to a group of medicines called steroids.

Dexavet (Winston) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (Winston) may also be used to prevent organ transplant rejection after a transplant. Dexavet (Winston) may be used for other purposes as decided by your doctor. Dexavet (Winston) belongs to a group of medicines called steroids.

Dexavet is a potent synthetic member of the glucocorticoid class of steroid hormones. It acts as an anti-inflammatory and immunosuppressant. Its potency is about 20-30 times that of hydrocortisone and 4-5 times of prednisone.

Dexavet (L.S.) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (L.S.) may also be used to prevent organ transplant rejection after a transplant. Dexavet (L.S.) may be used for other purposes as decided by your doctor. Dexavet (L.S.) belongs to a group of medicines called steroids.

Dexavet (Panbiotic) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (Panbiotic) may also be used to prevent organ transplant rejection after a transplant. Dexavet (Panbiotic) may be used for other purposes as decided by your doctor. Dexavet (Panbiotic) belongs to a group of medicines called steroids.

Dexavet (Yung Chi) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (Yung Chi) may also be used to prevent organ transplant rejection after a transplant. Dexavet (Yung Chi) may be used for other purposes as decided by your doctor. Dexavet (Yung Chi) belongs to a group of medicines called steroids.

Dexavet (Tai Yu) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (Tai Yu) may also be used to prevent organ transplant rejection after a transplant. Dexavet (Tai Yu) may be used for other purposes as decided by your doctor. Dexavet (Tai Yu) belongs to a group of medicines called steroids.

Treatment of rheumatoid arthritis, rheumatoid fever, collagen fever, allergic diseases, arthritis, serious dermal diseases, keloid, burn, surgical anaphylaxis.

Dexavet (Standard) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (Standard) may also be used to prevent organ transplant rejection after a transplant. Dexavet (Standard) may be used for other purposes as decided by your doctor. Dexavet (Standard) belongs to a group of medicines called steroids.

Dexavet (Y.S.) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (Y.S.) may also be used to prevent organ transplant rejection after a transplant. Dexavet (Y.S.) may be used for other purposes as decided by your doctor. Dexavet (Y.S.) belongs to a group of medicines called steroids.

Dexavet (Sen Tai) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (Sen Tai) may also be used to prevent organ transplant rejection after a transplant. Dexavet (Sen Tai) may be used for other purposes as decided by your doctor. Dexavet (Sen Tai) belongs to a group of medicines called steroids.

Dexavet (The Central) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (The Central) may also be used to prevent organ transplant rejection after a transplant. Dexavet (The Central) may be used for other purposes as decided by your doctor. Dexavet (The Central) belongs to a group of medicines called steroids.

Dexavet (Astar) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (Astar) may also be used to prevent organ transplant rejection after a transplant. Dexavet (Astar) may be used for other purposes as decided by your doctor. Dexavet (Astar) belongs to a group of medicines called steroids.

Dexavet (M.T.) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (M.T.) may also be used to prevent organ transplant rejection after a transplant. Dexavet (M.T.) may be used for other purposes as decided by your doctor. Dexavet (M.T.) belongs to a group of medicines called steroids.

Dexavet (Update) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (Update) may also be used to prevent organ transplant rejection after a transplant. Dexavet (Update) may be used for other purposes as decided by your doctor. Dexavet (Update) belongs to a group of medicines called steroids.

Dexavet (C.I.) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (C.I.) may also be used to prevent organ transplant rejection after a transplant. Dexavet (C.I.) may be used for other purposes as decided by your doctor. Dexavet (C.I.) belongs to a group of medicines called steroids.

Dexavet (Meider) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (Meider) may also be used to prevent organ transplant rejection after a transplant. Dexavet (Meider) may be used for other purposes as decided by your doctor. Dexavet (Meider) belongs to a group of medicines called steroids.

Dexavet (Y.Y) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (Y.Y) may also be used to prevent organ transplant rejection after a transplant. Dexavet (Y.Y) may be used for other purposes as decided by your doctor. Dexavet (Y.Y) belongs to a group of medicines called steroids.

Indications:

Adult: PO Anti-inflammatory 0.75-9 mg/day in 2-4 divided doses. Test for Cushing\'s syndrome 0.5 mg 6 hrly for 48 hr after determining baseline 24-hr urinary 17-hydroxycorticosteroid concentrations. Acute exacerbations of multiple sclerosis 30 mg/day for 1 wk followed by 4-12 mg/day for 1 mth. IV Unresponsive shock As phosphate: Initial: 40 mg as a single dose, may repeat 2-6 hrly. Bacterial meningitis 0.15 mg/kg 4 times/day 10-20 mins before or w/ 1st dose of anti-infective treatment. Prophylaxis of nausea and vomiting associated with cytotoxic therapy 10-20 mg 15-30 mins before start of chemotherapy. IV/IM Cerebral oedema caused by malignancy As phosphate: Initial: 10 mg IV followed by 4 mg IM 6 hrly until response is achieved. Intra-articular Inflammatory joint diseases 0.8-4 mg depending on size of affected joint. For soft tissue: 2-6 mg. May repeat every 3-5 days to 2-3 wkly. Ophth Ocular inflammation As 0.1% susp: Apply 1-2 drops 4-6 times/day, up to hrly admin in more severe disease. As 0.05% oint: Apply 0.5-1 inch ribbon of oint up to 4 times/day.

Oral Anti-inflammatory

Adult: 0.75-9 mg daily in 2-4 divided doses; may also be given via IM/IV admin.

Child: 1 mth–18 yr: 10–100 mcg/kg daily in 1–2 divided doses via oral admin, adjusted according to response; up to 300 micrograms/kg daily may be used in emergency situations. Oral As a screening test for Cushing\'s syndrome

Adult: 0.5 mg every 6 hr for 48 hr after determining baseline 24-hr urinary 17-hydroxycorticosteroid (17-OHCS) concentrations. During the second 24 hr of Dexavet admin, urine is collected and analysed for 17-OHCS. Alternatively, after a baseline plasma cortisol determination, 1 mg may be given at 11 pm and plasma cortisol determined at 8 am the next morning. Plasma cortisol and urinary output of 17-OHCS are depressed after Dexavet admin in normal individuals but remain at basal levels in patients with Cushing\'s syndrome. Oral Acute exacerbations in multiple sclerosis

Adult: 30 mg daily for 1 wk followed by 4-12 mg daily for 1 mth.

Child: 1 mth–12 yr: 100–400 mcg/kg daily in 1–2 divided doses; 12–18 yr: Initially 0.5–24 mg daily. Max. 24 mg daily. Intravenous Unresponsive shock

Adult: As phosphate: Initially, 40 mg or 1-6 mg/kg as a single IV inj, may repeat every 2-6 hr. Continue high-dose treatment only until patient\'s condition has stabilised and not to be continued beyond 48–72 hr. Intravenous Bacterial meningitis

Adult: 0.15 mg/kg 4 times daily, to be given 10-20 min before or with the 1st dose of anti-infective treatment. Treatment should be given for the first 2-4 days of the anti-infective treatment.

Child: As phosphate: 2 mth–18 yr: 150 mcg/kg every 6 hr for 4 days, starting before or with 1st dose of antibacterial treatment. Intravenous Chemotherapy-related emesis

Adult: Prevention: 10-20 mg 15-30 minutes before admin of chemotherapy on each treatment day. For continuous infusion regimen: 10 mg every 12 hr on each treatment day. For midly emetogenic regimen: 4 mg every 4-6 hr. Parenteral Cerebral oedema caused by malignancy

Adult: As phosphate: 10 mg IV followed by 4 mg IM every 6 hr until response is achieved, usually after 12-24 hr. May reduce dosage after 2-4 days then gradually discontinued over 5-7 days. In severe cases, an initial dose of 50 mg IV may be given on day 1, with 8 mg every 2 hr, reduced gradually over 7-13 days. Maintenance dose: 2 mg 2-3 times daily.

Child: As phosphate: <35 kg: Initially 20 mg, then 4 mg every 3 hr for 3 days, then 4 mg every 6 hr for 1 day, then 2 mg every 6 hr for 4 days, then decrease by 1 mg daily. >35 kg: Initially 25 mg, then 4 mg every 2 hr for 3 days, then 4 mg every 4 hr for 1 day, then 4 mg every 6 hr for 4 days, then decrease by 2 mg daily. Doses are given via IV inj. Ophthalmic Ophthalmic inflammation

Adult: As 0.1% suspension: Apply 1-2 drops into the affected eye/s 4-6 times daily in mild disease, up to hrly admin in more severe disease. As 0.05% ointment: Apply 0.5-1 inch ribbon of ointment into the conjunctival sac(s) up to 4 times daily. Reduce to once daily dosing once conditon has improved. Intra-articular Inflammation, musculoskeletal and joint disorders

Adult: 0.8-4 mg depending on the size of the affected joint. For soft-tissue inj, 2-6 mg may be used. May repeat inj every 3-5 days to every 2-3 wk.

Dexavet (CCPC) helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Dexavet (CCPC) may also be used to prevent organ transplant rejection after a transplant. Dexavet (CCPC) may be used for other purposes as decided by your doctor. Dexavet (CCPC) belongs to a group of medicines called steroids.

Anti-inflammatory,As a screening test for Cushing’s syndrome,Acute exacerbations in multiple sclerosis,Unresponsive shock,Bacterial meningitis,Prophylaxis of nausea and vomiting associated with cytotoxic therapy,Cerebral oedema caused by malignancy,Ocular inflammation,Inflammatory joint diseases.

Dexavet Professional Veterinary Laboratories is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Professional Veterinary Laboratories decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Rivex Ophthalmics is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Rivex Ophthalmics decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Roxane Laboratories is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Roxane Laboratories decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Farmak is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Farmak decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Bel Mar is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Bel Mar decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Austin is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Austin decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet ECR Pharmaceuticals is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet ECR Pharmaceuticals decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Vetoquinol is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Vetoquinol decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Quad Pharmaceuticals is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Quad Pharmaceuticals decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Shreya Life Sciences is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Shreya Life Sciences decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Cytex Pharmaceuticals is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Cytex Pharmaceuticals decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet GNCLS Pilot Plant is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet GNCLS Pilot Plant decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Lans-Pharm is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Lans-Pharm decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Mayne Pharma is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Mayne Pharma decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Impax Laboratories is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Impax Laboratories decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Akrikhin is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Akrikhin decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Organon is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Organon decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Whiteworth Town is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Whiteworth Town decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Alpharma is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Alpharma decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Akorn is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Akorn decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Valenta Pharmaceuticals is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Valenta Pharmaceuticals decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet M.J. Biopharm is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet M.J. Biopharm decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet PVT Form is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet PVT Form decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Luitpold Pharmaceuticals is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Luitpold Pharmaceuticals decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Beta-Lek is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Beta-Lek decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Par Pharmaceutical is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Par Pharmaceutical decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Wyeth is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Wyeth decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Baxter is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Baxter decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Bausch and Lomb is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Bausch and Lomb decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet International Medication Systems is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet International Medication Systems decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Sola Barnes Hind is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Sola Barnes Hind decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Russian Cardiology Research Industrial Complex Ministry of Health is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet Russian Cardiology Research Industrial Complex Ministry of Health decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

Dexavet Russian Cardiology Research Industrial Complex Ministry of Health inhibits the activity of phospholipase A2, which leads to suppression of the synthesis of prostaglandins and leukotrienes.

Dexavet KRKA is a glucocorticosteroid. This medication Inhibits the function of leukocytes and tissue macrophages. Dexavet restricts the migration of leukocytes in the area of inflammation. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexavet KRK

Management of primary or secondary adrenal cortex insufficiency, rheumatic disorders, collagen diseases, dermatologic diseases, allergic states, allergic and inflammatory ophthalmic processes, respiratory diseases, hematologic disorders, neoplastic diseases, cerebral edema associated with primary or metastatic brain tumor, craniotomy or head injury, edematous states (caused by nephritic syndrome), GI diseases, multiple sclerosis, tuberculous meningitis, trichinosis with neurologic or myocardial involvement.

Indications: Replacement therapy: Adrenal insufficiency.

Adrenogenital syndrome.

Nonendocrine diseases: Rheumatoid arthirits.

Osteoarthritis, Acute gouty arthirits.

Collagen diseases e.

g.

systemic lupus erythematosus, polyarteritis nodosa, dermatomyositis, nephritic syndrome, glomerulonephritis and related diseases.

Severe allergic reactions e.

g.

anaphylaxis, angioneurotic edema, urticaria and serum sickness and related diseases.

Autoimmune diseases e.

g.

haemolytic anaemia, idiopathic thrombocytopenic purpura, active chronic hepatitis and related diseases.

Other lung diseases e.

g.

pulmonary edema, accelerate lung maturation and surfactant production in the foetus and prevent respiratory distress syndrome at birth.

Infective diseases e.

g.

severe forms of tuberculosis, severe lepra reaction, certain forms of bacterial meningitis and Pneumocystis carinii pneumonia with hypoxia in AIDS patients along with proper antibiotic c

Active ingredients: Dexamethasone
Unit description, dosagePrice, USD

List of dexavet brand and generic drugs

Dexavene (France)
Dexaveto
Injectable; Injection; Dexamethasone Sodium Phosphate 0.26%
Dexazen
Dexazona Injections
Injectable; Injection; Dexamethasone Phosphate
Dexazone (France)
Dexazone 0.5 mg x 100's
Dexazone 0.5 mg x 500's
Dexazone 0.5 mg x 1000's
Dexcin (India)
Dexcin Dexamethasone phosphate 0.1 %,Neomycin sulphate 0.5 %, Boricacid 1.2 %. EYE-DPS / 5ml$ 0.28
5ml$ 0.28
Dexcin E/E 10 ml Drop$ 0.17
Dexcor (Bangladesh)
Dexedrina
Dexicar
Dexicol
Dexicol 8 mg Injection$ 0.06
Dexicort (Philippines)
Dexicort 500 mcg x 100's
Dexinga (Sri Lanka)
Dexinolon
Dexinoral
Dexium SP (United States)
Dexmene
Dexmetha (Singapore)
Dexmetha 0.5 mg x 1's
Dexmethsone (Australia)
Tablet; Oral; Dexamethasone 0.5 mg
Tablet; Oral; Dexamethasone 4 mg
Dexmethsone 4 mg x 30's$ 35.00
Tablets; Oral; Dexamethasone 0.5 mg
Tablets; Oral; Dexamethasone 4 mg
Dexnor (India)
Dexnor 8mg INJ / 2ml$ 0.18
8 mg x 2ml$ 0.18
Dexnor 8 mg Injection$ 0.09
Dexo (Argentina, Myanmar)
Dexol 5 (Australia, New Zealand)
Dexon (Bangladesh)
Dexon 4 mg/1 mL x 1 mL x 10's
Dexon 4 mg/1 mL x 100's
Dexon 4 mg/1 mL x 2 mL
Dexon 4 mg/1 mL x 10 mL
Dexona (Ethiopia, India, Kenya, Latvia, Myanmar, Oman, Sri Lanka, Tanzania, Uganda, Zambia)
Solution; Ophthalmic, Otic; Dexamethasone Sodium Phosphate 0.1%; Neomycin Sulfate 0.5%
DEXONA Capsule/ Tablet / 0.5mg (10 units)$ 0.04
DEXONA Injection / 4mg per ml (2ml units)$ 0.14
DEXONA Injection / 20mg (5ml units)$ 0.83
DEXONA Capsule/ Tablet / 0.5mg (1000 units)$ 2.87
Dexona 0.5mg TAB / 10$ 0.03
Dexona 0.5mg/ml DPS / 10ml$ 0.13

Show all Dexavet generic names
 
Privacy Policy
© 2003 - 2014 igenericdrugs.com All Rights Reserved
 
Disclamer